QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 6 November 2019Portfolio NewsArtios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
- 5 November 2019Portfolio NewsHealthify Raises $16M to Integrate Health and Social Services
- 23 October 2019Portfolio NewsClarify Medical Closes $18M Series A Round to Commercialize its Connected Home Phototherapy System in the US
- 21 October 2019Portfolio NewsSkyKnight Capital Invests in Home Healthcare Leader AeroCare
- 10 October 2019Portfolio NewsRheostat Therapeutics Announces Rebrand to Caraway Therapeutics and New Kendall Square Office
- 10 October 2019SV NewsDDF hosts Second Annual Forum to review progress in novel dementia therapeutics
- 8 October 2019Portfolio NewsAVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
- 1 October 2019Portfolio NewsEndotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution
- 30 September 2019Portfolio NewsDDF notes Ribometrix strategic collaboration with Vertex Pharmaceuticals to discover and develop RNA-targeted small molecule therapeutics
- 27 September 2019Portfolio NewsMisonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
- 27 September 2019Portfolio NewsDDF notes Ribometrix raises $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform with Investment from DDF
- 24 September 2019Portfolio NewsArtios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States